Delivery Order SPE2DB22D1103-SPE2DB25FTGC2
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,023.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price, with a final completion date of February 5, 2025. The contract provides for the delivery of VYVANSE 60 MG CAPSULE 100S, a medication used for the treatment of various health conditions. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $3,148.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a completion date of October 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,129.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
This federal contract award, valued at $1,808.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565237590 VYVANSE 50 MG CAPSULE 100S, a specialty medication. The award date is July 22, 2024, with a completion date of July 23, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $4,392.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,052,546 units of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a completion date of March 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $1,337.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566545113 VYVANSE 40 MG CAPSULE 100S, a prescription medication, with a completion date of November 26, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,319.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567330901 - VYVANSE 50 MG CAPSULE 100S, a medication used for the treatment of various conditions. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 21, 2025. This award is part of a larger Indefinite...
This federal contract award, valued at $3,247.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,703,805 units of the prescription medication VYVANSE 50 MG CAPSULE 100S, with a completion date of May 24, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award, valued at $1,114.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for VYVANSE 40 MG CAPSULE 100S, a medication used for treating certain mental health conditions. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 13, 2024. This award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,543.41 firm fixed-price delivery order is for the supply of 4,563,894,518 units of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...